Get in Touch



SL-356

Doxazosin-d6 mesylate, 98% (CP)

Isotopic Purity : 
99 atom % D
CAS No. : 
[1006718-70-2]    
MDL No. : 
MFCD28386066
Related CAS No. : 
[77883-43-3] of the unlabelled compound
Synonyms : (4-(4-Amino-6,7-dimethoxy-d6-quinazolin-2-yl)piperazin-1-yl)(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanone methanesulfonate; Doxazosin-d6 methanesulfonate

Price and Availability
Pack Size Price in USD Quantity Availability Shipping Status
5MG1480.00 Back Order Estimated to Ship on 06.01.2024
10MG2480.00 Back Order Estimated to Ship on 06.01.2024
Chemical Properties
C23H19D6N5O5 ยท CH3SO3H 553.62
Solid Not available
For Laboratory research use only, not for drug, household or other uses.
Applications : Doxazosin-d6 is deuterium labelled analogue of Doxasin, an alpha1-adrenoceptor antagonist and significantly inhibited prostate (PC3) and bladder cancer (HT1376) cell growth.
References : Siddiqui E.J. et.al.: Anticancer Res.,25(6B), 4281, 2005.
Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term storage.
Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.

To receive price and delivery information on larger quantities, please complete the form below and we will respond promptly.

If you login prior to completion of the form, your contact information will automatically populate.

Your request for quote will also be accepted by e-mail at sales@syninnova.com or Fax: +1 780 485 2963.

Product ID : SL-356

Product Name : Doxazosin-d6 mesylate

Note : If you do not find your required compound in our catalogue, or not commercially available, please contact us, we will assist you to get your desired molecule. We only charge if we deliver to your satisfaction.

Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for COA. Thank you!

Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for HNMR. Thank you!